Citation Tools
PDFClinical aspects
Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis